Modeling tandem AAG8-MEK inhibition in melanoma cells

Drug resistance presents a challenge to the treatment of cancer patients, especially for melanomas, most of which are caused by the hyperactivation of MAPK signaling pathway. Innate or acquired drug-resistant relapse calls for the investigation of the resistant mechanisms and new anti-cancer drugs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bing, Kawahara, Masahiro, Nagamune, Teruyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101763/
https://www.ncbi.nlm.nih.gov/pubmed/24634165
http://dx.doi.org/10.1002/cam4.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101763/
https://www.ncbi.nlm.nih.gov/pubmed/24634165
http://dx.doi.org/10.1002/cam4.233

Ejemplares similares